公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2008 | The early presentation of Creutzfeldt-Jacob disease: Two cases report in middle Taiwan | Chuang C.-S.; Wu S.-L.; Lo M.-C.; MING-CHING SHEN ; Liu T.-J. | Journal of Internal Medicine of Taiwan | 0 | | |
2023 | Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan | MING-CHING SHEN ; SHENG-CHIEH CHOU ; Chiou, Shyh-Shin; Lin, Pei-Chin; Chen, Yeu-Chin; Lin, Hsuan-Yu; Lee, Yang-Cheng; Huang, Cih-En; Weng, Te-Fu; Huang, Ting-Huan; Chung, Chih-Yuan; Chen, Jiann-Shiuh; Chen, Shu-Huey; Cheng, Shin-Nan; Hsiao, Chih-Cheng; Huang, Yen-Min; Chen, Shih-Hsiang; Yu, Yuan-Bin; Lin, Shih-Chiang; Lin, Ching-Yeh; Peng, Ching-Tien; Wang, Jiaan-Der | Haemophilia : the official journal of the World Federation of Hemophilia | 0 | 0 | |
1999 | Engineered recombinant factor VII Q217 variants with altered inhibitor specificities | Chang Y.-J.; Hamaguchi N.; Chang S.-C.; Ruf W.; MING-CHING SHEN ; SHU-WHA LIN | Biochemistry | 15 | 15 | |
2007 | Epidemiology of multiple myeloma in Taiwan: Increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years | SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WEN-CHUNG LEE ; WOEI TSAY ; ANN-LII CHENG ; Wang C.-H.; YAO-CHANG CHEN ; MING-CHING SHEN ; HWEI-FANG TIEN | Cancer | 84 | 71 | |
2001 | Epitope mapping of factor VIII inhibitor antibodies of Chinese origin | Huang C.-C.; MING-CHING SHEN ; Chen J.-Y.; Hung M.-H.; Hsu T.-C.; SHU-WHA LIN | British Journal of Haematology | 9 | 9 | |
2023 | Estimating the impact of improved management of haemophilia a on clinical outcomes and healthcare utilisation and costs | Chandrasekaran, Ravichandran; Dávoli, Mauro; Muda, Zulaiha; Pérez-Lozano, Uendy; Salhi, Naouel; Saxena, Nakul; MING-CHING SHEN ; Song, HyeRyoung Haylee; Sosothikul, Darintr; Soto-Arellano, Veronica Soledad; Solev, Igor | BMC research notes | 0 | 0 | |
1993 | Evaluation of performance for automated differential leucocyte counting on Sysmex NE-8000 by NCCLS recommended protocol, H20-T | CHUNG-YI HU ; CHIU-HWA WANG; HWEI-MEI CHUANG; MING-CHING SHEN | Clinical & Laboratory Haematology | 11 | 0 | |
1992 | Experience of desmopressin (DDAVP) administration in patients with congenital and acquired bleeding disorders | WOEI TSAY ; MING-CHING SHEN | Journal of the Formosan Medical Association | 5 | 0 | |
1999 | Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - The occurrence of retinoic acid syndrome is a risk factor | BOR-SHENG KO ; JIH-LUH TANG ; YAO-CHANG CHEN ; MING YAO ; Wang C.-H.; MING-CHING SHEN ; HWEI-FANG TIEN | Leukemia | 77 | 61 | |
2001 | Factor V Arg306 → Gly mutation is not associated with activated protein C resistance and is rare in Taiwanese Chinese | MING-CHING SHEN ; LIN, JEN-SHIOU; WOEI TSAY | Thrombosis and Haemostasis | 16 | 16 | |
2000 | Factor V arg306-> Gly is not a risk factor for venous thrombophilia in Taiwanese Chinese | Lin J.S.; MING-CHING SHEN ; Tsai W.; Lin B.; Lin B.B.; Hong M.H. | Fibrinolysis and Proteolysis | 0 | | |
1995 | Factor VIII gene inversions in severe hemophilia A: Results of an international consortium study | Antonarakis S.E.; Rossiter J.P.; Young M.; Horst J.; De Moerloose P.; Sommer S.S.; Ketterling R.P.; Kazazian Jr. H.H.; N?grier C.; Vinciguerra C.; Gitschier J.; Goossens M.; Girodon E.; Ghanem N.; Plassa F.; Lavergne J.M.; Vidaud M.; Costa J.M.; Laurian Y.; Lin S.-W.; Lin S.-R.; MING-CHING SHEN ; Lillicrap D.; Taylor S.A.M.; Windsor S.; Valleix S.V.; Nafa K.; Sultan Y.; Delpech M.; Vnencak-Jones C.L.; Phillips III J.A.; Ljung R.C.R.; Koumbarelis E.; Gialeraki A.; Mandalaki T.; Jenkins P.V.; Collins P.W.; Pasi K.J.; Goodeve A.; Peake I.; Preston F.E.; Schwartz M.; Scheibel E.; Ingerslev J.; Cooper D.N.; Millar D.S.; Kakkar V.V.; Giannelli F.; Naylor J.A.; Tizzano E.F.; Baiget M.; Domenech M.; Altisent C.; Tusell J.; Beneyto M.; Lorenzo J.I.; Gaucher C.; Mazurier C.; Peerlinck K.; Matthijs G.; Cassiman J.J.; Vermylen J.; Mori P.G.; Acquila M.; Caprino D.; Inaba H. | Blood | 285 | 268 | |
1998 | Familial macrothrombocytopenia with granulocyte inclusion: A clinical and laboratory problem | Lin J.-S.; MING-CHING SHEN ; Wang C.-H.; Lin C.-T. | Journal of the Formosan Medical Association | 2 | 3 | |
2020 | A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan | Huang Y.-C.; Shih Y.-H.; Lin C.-Y.; Chiu P.-F.; Kuo S.-F.; Lin J.-S.; MING-CHING SHEN | International Journal of Hematology | 2 | 1 | |
2021 | First reported case of congenital thrombotic thrombocytopenic purpura in Taiwan with novel mutation of ADAMTS13 gene | SHENG-CHIEH CHOU ; Lin, Dong-Tasmn; Lin, Ching-Yeh; Huang, Ying-Chih; Hsieh, Han-Ni; MING-CHING SHEN | International journal of hematology | 0 | 0 | |
2003 | A first Taiwanese Chinese family of type 2B von Willebrand disease with R1306W mutation | MING-CHING SHEN ; Lin J.-S.; Lin D.S.-Y.; Hsu S.-C.; Lin B. | Thrombosis Research | 1 | 1 | |
2014 | Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency | Liu H.-C.; Lin T.-M.; Eng H.-L.; Lin Y.-T.; MING-CHING SHEN | Thrombosis Research | 6 | 5 | |
1993 | Genetic basis and carrier detection of hemophilia B of Chinese origin | SHU-WHA LIN ; MING-CHING SHEN | Thrombosis and Haemostasis | 16 | 17 | |
1995 | Genetic diagnosis of haemophilia A of Chinese origin | Lin S.?R.; Chang S.?C.; Lee C.?C.; MING-CHING SHEN ; SHU-WHA LIN | British Journal of Haematology | 11 | 11 | |
1994 | Hematophagic histiocytosis: a clinicopathologic analysis of 23 cases with special reference to the association with peripheral T-cell lymphoma. | Chang C.S.; Wang C.H.; Su I.J.; YEE-CHUN CHEN ; MING-CHING SHEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 50 | 0 | |